echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Do women taking birth control pills help reduce the risk of severe COVID-19?

    Do women taking birth control pills help reduce the risk of severe COVID-19?

    • Last Update: 2020-09-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Men make up 55 per cent of coVID-19 deaths in the vast majority of age groups in England and Wales.
    only in the age group over 85 years of age, COVID-19 has more women than men, mainly because there are more female elders in this age group.
    women have higher levels of estrogen.
    generally believe that estrogen affects the number of immune cells the body produces and how they respond to infection.
    , does it have that effect on COVID-19? Dr Karla Lee, who led the study, said it had been assumed that pre-menophasy women had higher levels of estrogen and were less likely to develop severe COVID-19 than post-menophasic women of the same age and body mass index (BMI).
    ,000-year-old oral contraceptive pill, called deoxyprogeminated estradiol tablets, is a safe, efficient and low-side third-generation short-acting oral contraceptive pill.
    women of childbearing age who take the pill, will the associated incidence decrease? Can you verify these assumptions? Comparing the cases of COVID-19 infection in similar groups that were not taken, it was found that the severity of COVID-19 infection was lower among young women who took the compound oral contraceptive pill.
    women who took the compound oral contraceptive pill were on average 13 percent less likely to develop COVID-19.
    suggests that estrogen in the compound oral contraceptive pill may provide some protection.
    women aged 18-45 who took oral contraceptives had a lower rate of COVID-19 infection and a lower rate of persistent coughing, delirium, anorexia, eating a meal without a meal, severe fatigue, pain and other symptoms.
    were also significantly reduced for women aged 18-45 who took oral contraceptives.
    results support this hypothesis.
    post-menomanan women, the risk of infection increased by more than 20 percent compared to pre-menomanan women, who had a 22 percent increased risk.
    study also showed that post-menoanth women were more likely to be infected with COVID-19 than pre-menoanth women.
    women in the 45-50 age group are most at risk, with reported symptoms including loss of smell, fever and persistent cough, and a significantly higher proportion of those in this age group who need to be hospitalized for oxygen absorption.
    post menotinal women aged 50-65 who used hormone replacement therapy were associated with an expected increase in COVID-19 infection rates, but not hospitalization rates.
    lack of information about the type of alternative therapy, the route and course of treatment, the researchers suggest that the effects of hormone replacement therapy should be viewed with caution.
    the results of this study also help explains why women are less likely than men to be infected with COVID-19.
    Co-author Dr Ricardo Costeira, of King's College London, said he hoped the findings would help provide information on ongoing biomedical research and clinical trials in the field.
    resources: s1. Ricardo Costeira. Post-menopausal women at higher risk of developing severe COVID-19, study finds. Aug 4, 2020.Henry Bodkin. Women who take the tyony pill are less likely to develop serious coronavirus, study finds. Aug 4, 2020. Retrieved Aug 5, 2020 from.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.